By Editorial Staff
December 1, 2025
In the landscape of modern patient advocacy, few organizations have managed to bridge the gap between clinical necessity and communal support as effectively as Sharsheret. What began as a desperate search for connection by a young mother in 2001 has evolved into a global powerhouse, providing vital resources to over 275,000 individuals annually. As the organization marks a decade since the passing of its founder, Rochelle Shoretz, her sons, Shlomo and Dovid Mirsky, are calling on the public to ensure the organization’s mission remains a cornerstone of the Jewish community’s healthcare infrastructure.
The Genesis: A Dining Room Table Movement
In 2001, the world of cancer care was vastly different. Conversations surrounding breast and ovarian cancer were often relegated to the shadows, steeped in taboo and isolation. For Rochelle Shoretz, a young mother of two, the diagnosis was not merely a medical challenge but a profound existential crisis that left her searching for a peer who understood the unique intersection of parenting, career, and Jewish identity.
Her breakthrough came in the form of a connection with Lauryn Weiser, a fellow Jewish mother navigating a similar path. That singular relationship—the power of one woman helping another—became the blueprint for Sharsheret (Hebrew for "chain").
"Mom took that idea and ran with it," recall Shlomo and Dovid Mirsky. What started as five women gathering around a private dining room table to share stories and resources has since burgeoned into an international movement, providing a lifeline to thousands of families who might otherwise have faced their diagnosis in silence.
A Chronology of Impact: From Local Support to Global Reach
The history of Sharsheret is a testament to the power of community-led intervention. Since its inception, the organization has navigated several critical phases of development:

- 2001: Rochelle Shoretz founds Sharsheret, establishing a national support network specifically designed for Jewish women and families facing breast and ovarian cancer.
- Early 2000s: The organization introduces foundational programs, such as the "Busy Box," which provided age-appropriate activities to help children cope with the emotional and logistical realities of a parent’s treatment.
- 2015: The passing of Rochelle Shoretz marks a period of profound transition. While the organization mourned its founder, it entered a decade of aggressive scaling and professionalization.
- 2015–2025: Sharsheret transitions from a grassroots initiative to a sophisticated, data-driven national nonprofit, expanding its services to include genetic counseling support, financial assistance, and mental health resources.
- Present Day: Sharsheret serves over 275,000 people annually, cementing its role as the premier organization for Jewish breast and ovarian cancer support.
Supporting Data: The Scope of the Crisis and the Response
The necessity for Sharsheret’s work is underscored by sobering statistics regarding breast and ovarian cancer within the Jewish community. Genetic predispositions—most notably BRCA1 and BRCA2 mutations—are significantly more prevalent in individuals of Ashkenazi Jewish descent, occurring at a rate of approximately 1 in 40, compared to 1 in 400 in the general population.
Sharsheret has positioned itself at the forefront of this specific healthcare challenge:
- Clinical Outreach: The organization partners with healthcare providers to ensure that patients are not just treated medically, but supported holistically.
- Demographic Reach: By serving over 275,000 people annually, Sharsheret has effectively decentralized the support process, moving it from the clinical confines of a hospital to the comfort of the family home.
- Resource Distribution: Through specialized programming, they have managed to reduce the "care gap" for families who struggle with the psychological and financial burdens of long-term cancer care.
Official Responses and the Call to Action
For Shlomo and Dovid Mirsky, the organization is more than a charity; it is a living monument to their mother’s life. In a recent statement, they reflected on the milestone of the tenth anniversary of her passing.
"It’s hard to believe it’s been 10 years since Mom’s passing," the brothers stated. "She has missed so many milestones—from graduations to grandchildren—but we see her influence everywhere. We were personally served by Sharsheret, and we know firsthand how the ‘Busy Box’ and the peer-to-peer support systems change the trajectory of a family’s experience during treatment."
The brothers are now spearheading a year-end fundraising initiative to secure the financial future of the organization. "Please join us in making a year-end donation to Sharsheret to ensure that thousands of families just like ours have Sharsheret to lean on in their time of need," they urged. The campaign is currently directing donors to link.Sharsheret.org/EOY, emphasizing that every dollar contributes to a "healthier and brighter future for the next generation."
Implications: The Future of Patient Advocacy
The success of Sharsheret offers a blueprint for other niche-focused nonprofits. By identifying a specific cultural or demographic need, organizations can provide a level of empathy that broader healthcare systems often lack.

The Power of Peer Support
One of the most significant implications of Sharsheret’s model is the psychological benefit of peer-to-peer support. The organization treats cancer not as a private medical condition, but as a family-wide experience. By providing resources for children and spouses, they mitigate the trauma that often accompanies a chronic illness diagnosis.
Adapting to the Digital Age
As Sharsheret looks toward the next decade, the focus is shifting toward digital accessibility. The ability to provide instant, high-quality, and culturally sensitive resources online has allowed the organization to maintain its personal touch even as it scales to serve hundreds of thousands of people.
Sustainability and Legacy
The Mirsky brothers’ call to action serves as a reminder that the sustainability of such organizations depends on communal investment. As the healthcare landscape becomes increasingly complex, specialized organizations like Sharsheret act as the "connective tissue" that ensures no patient is left to navigate the system alone.
Conclusion: A Living Legacy
Rochelle Shoretz once dreamed of a world where no Jewish woman would face breast or ovarian cancer alone. Today, her organization stands as the realization of that vision. The growth from a small group of women to an international movement is not just a triumph of logistics; it is a triumph of empathy.
As the year draws to a close and the community observes the season of Chanukah, the message from the Shoretz-Mirsky family is clear: the light of her legacy continues to burn bright through the help provided to those currently in the fight. To contribute to this ongoing mission and ensure that the "chain" remains unbroken for the next generation, supporters are invited to engage with the year-end campaign and become a part of the history of this vital organization.
To learn more about Sharsheret or to make a year-end donation, please visit link.Sharsheret.org/EOY.
